Takeda to Challenge Irish Authorities’ Break Fee Tax Assessment

August 3, 2021
Takeda Pharmaceutical said on August 2 that it is challenging the latest decision by Irish authorities on the tax assessment of a breakup fee Shire received from AbbVie linked to their scrapped merger deal in 2014. The issue dates back...read more